AtriCure Announces Preliminary Results For Fourth Quarter And Full Year 2015 Updates 2016 Guidance

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced preliminary financial results for fourth quarter and full year 2015 and updated 2016 financial guidance.

MORE ON THIS TOPIC